Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides selectively lethal to malignant and transformed mammalian cells

Peptides selectively lethal to malignant and transformed mammalian cells

US Patent 7745405 · Granted Jun 29, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating cancer2021
Methods for treating cancer2020
Methods for treating cancer2019
Peptides for treating cancer2017
Small molecule cancer treatments that cause necrosis in cancer cells but do not 2017
Phenotypic reversion of pancreatic carcinoma cells2015
Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rat2014
Peptides selectively lethal to malignant and transformed mammalian cells2011
Peptides selectively lethal to malignant and transformed mammalian cells2009
Peptidomimetics for the treatment of HIV infection1999
Peptidomimetics inhibiting the oncogenic action of p21 ras1999
Peptides inhibiting the oncogenic action of p21 ras1998